Eric R. Olson
2018
In 2018, Eric R. Olson earned a total compensation of $1.2M as Chief Scientific Officer at Syros Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $189,219 |
|---|---|
| Option Awards | $569,408 |
| Salary | $430,000 |
| Other | $270 |
| Total | $1,188,897 |
Olson received $569.4K in option awards, accounting for 48% of the total pay in 2018.
Olson also received $189.2K in non-equity incentive plan, $430K in salary and $270 in other compensation.
Rankings
In 2018, Eric R. Olson's compensation ranked 8,329th out of 14,244 executives tracked by ExecPay. In other words, Olson earned more than 41.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,329 out of 14,244 | 42nd |
Division Manufacturing | 3,302 out of 5,765 | 43rd |
Major group Chemicals And Allied Products | 1,239 out of 2,128 | 42nd |
Industry group Drugs | 1,035 out of 1,817 | 43rd |
Industry Pharmaceutical Preparations | 807 out of 1,391 | 42nd |
Source: SEC filing on April 28, 2020.
Olson's colleagues
We found three more compensation records of executives who worked with Eric R. Olson at Syros Pharmaceuticals in 2018.
News
Syros Pharmaceuticals CEO Nancy Simonian's 2023 pay falls 59% to $1.4M
April 23, 2024
Syros Pharmaceuticals CEO Nancy Simonian's 2022 pay rises 12% to $3.5M
April 21, 2023
Syros Pharmaceuticals CEO Nancy Simonian's 2021 pay jumps 23% to $3.1M
April 21, 2022
Syros Pharmaceuticals CEO Nancy Simonian's 2020 pay falls 30% to $2.5M
April 29, 2021
Syros Pharmaceuticals CEO Nancy Simonian's 2019 pay rises 19% to $3.6M
April 28, 2020
Syros Pharmaceuticals CEO Nancy Simonian's 2018 pay jumps 36% to $3M
April 25, 2019